Cognitive Biases Modification Treatment for Social Anxiety
CBMSP
1 other identifier
interventional
95
1 country
1
Brief Summary
Adults with Social Phobia will be randomly assigned to either an attention bias modification treatment, interpretation bias modification treatment, both, or a placebo control condition not designed to change cognitive bias patterns. Outcome measures will be social anxiety symptoms and severity as measured by gold standard questionnaires as well as diagnosis of social phobia disorder and symptom counts derived from structured clinical interviews based on DSM-IV criteria. The investigators expect to find significant reduction in social anxiety symptoms in the Treatment groups relative to the placebo control group. The investigators want to find out the relative efficacy of attention and interpretation oriented treatments and the combination of the two.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_2
Started Jan 2012
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 29, 2011
CompletedStudy Start
First participant enrolled
January 1, 2012
CompletedFirst Posted
Study publicly available on registry
January 2, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2014
CompletedDecember 2, 2014
December 1, 2014
2.2 years
December 29, 2011
December 1, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Social Anxiety Scale (LSAS) - diagnostic interview
LSAS is a 24-items clinician-administered scale developed for the assessment of fear and avoidance associated with social. The LSAS assesses a wide range of both social interaction and performance/observation situations, which are rated for degree of fear/anxiety and frequency of avoidance.
Expected time frame of 6 weeks per participant. Participants will be assessed before and after the administration of the training/control protocols
Secondary Outcomes (1)
The Mini International Neuropsychiatric Interview (MINI).
expected time frame of 6 weeks per participant. Participants will be assessed before and after the administration of the training/control protocols
Study Arms (4)
Placebo
PLACEBO COMPARATORrepeated trials of a dot-probe task and repeated trials of an interpretation task, both not intended to change threat-related biases patterns.
Attention Bias Modification (ABM)
EXPERIMENTALAttention training via repeated trials of a dot-probe task intended to direct attention away from threat stimuli.
Interpretation Bias Modification (IBM)
EXPERIMENTALInterpretation training intended to facilitating a more benign interpretation bias
Attention and interpretation biases modification
EXPERIMENTALAttention and interpretation training intended to direct cognitive biases away from threat stimulus.
Interventions
Attention training using a computerized spatial attention task (dot-probe) modified to alter threat-related attention patterns.
Interpretive Bias Modification Treatment (IBMT) using a computerized task modified to facilitate a more benign interpretation bias.
Attention and interpretation training using a computerized tasks not intended to alter threat-related biases patterns.
Attention and interpretation training via computerized tasks intended to direct attention away from threat stimuli and to facilitate a more benign interpretation bias.
Eligibility Criteria
You may qualify if:
- People suffering from social anxiety
You may not qualify if:
- Pharmacological or Psychological treatment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Tel-Aviv University
Tel Aviv, Israel
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Study Principal Investigator
Study Record Dates
First Submitted
December 29, 2011
First Posted
January 2, 2012
Study Start
January 1, 2012
Primary Completion
March 1, 2014
Study Completion
March 1, 2014
Last Updated
December 2, 2014
Record last verified: 2014-12